药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Carfentanil
Bunazosin
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Bunazosin.
Carfentanil
Trimazosin
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Trimazosin.
Carfentanil
Brexpiprazole
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Brexpiprazole.
Carfentanil
Indoramin
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Indoramin.
Carfentanil
Asenapine
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Asenapine.
Carfentanil
Pizotifen
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Pizotifen.
Carfentanil
Zuclopenthixol
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Zuclopenthixol.
Carfentanil
Thioproperazine
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Thioproperazine.
Carfentanil
Acepromazine
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Acepromazine.
Carfentanil
Periciazine
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Periciazine.
Carfentanil
Desvenlafaxine
Desvenlafaxine may increase the tachycardic activities of Levosalbutamol.
Carfentanil
Milnacipran
Milnacipran may increase the tachycardic activities of Levosalbutamol.
Carfentanil
Metergoline
Metergoline may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Carfentanil
Terguride
Terguride may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Carfentanil
Dihydroergocryptine
Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Carfentanil
Dihydroergocristine
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Carfentanil
Dihydroergocornine
Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Carfentanil
Lysergic acid diethylamide
Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Carfentanil
Betahistine
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Betahistine.
Carfentanil
Atosiban
The risk or severity of adverse effects can be increased when Levosalbutamol is combined with Atosiban.